Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Opyl Limited
  6. Summary
    OPL   AU0000070856

OPYL LIMITED

(OPL)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
0.135 0.14 0.135 0.135 0.135 Last
70643 15585 10907 2000 51249 Volume
0.00% +3.70% -3.57% 0.00% 0.00% Change
Estimated financial data (e)
Sales 2020 0,62 M 0,45 M 0,45 M
Net income 2020 -0,93 M -0,67 M -0,67 M
Net cash position 2020 0,80 M 0,58 M 0,58 M
P/E ratio 2020 -3,46x
Yield 2020 -
Sales 2021 0,77 M 0,56 M 0,56 M
Net income 2021 -1,14 M -0,83 M -0,83 M
Net cash position 2021 2,32 M 1,68 M 1,68 M
P/E ratio 2021 -6,36x
Yield 2021 -
Capitalization 7,33 M 5,33 M 5,32 M
EV / Sales 2020 2,95x
EV / Sales 2021 9,71x
Nbr of Employees -
Free-Float 78,4%
More Financials
Company
Opyl Limited s a new generation Australian company. The Company provides biopharma and health organizations access to emerging artificial intelligence (AI)-assisted technologies and guidance to understand and improve healthcare design, development and delivery. The Company is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for... 
More about the company
All news about OPYL LIMITED
08/26Opyl Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
07/02OPYL : Patient Recruitment Platform Signs MOU With Australian Regenerative Medic..
MT
07/01Opyl Limited Announces Clinical Trial Recruitment Platform Opin Enters Global..
CI
05/21OPYL : Introduces Clinical Trial Matching Platform; Shares Up 7%
MT
05/20Opyl Limited Introduces Opin - Match Patients to Clinical Trials
CI
05/04Opyl Limited Appoints Megan Robertson as Non-Executive Director to its Board
CI
04/21OPYL : Raises $1 Million via Share Purchase Plan to Execute Growth Plans
MT
04/15OPYL : Clinical Trial Recruitment Platform Goes Live; Shares Gain 3%
MT
04/14Opyl Limited Announces Clinical Trial Recruitment Platform Update
CI
04/01OPYL : Share Purchase Plan Offer Booklet
PU
03/30OPYL : Completes Capital Raising; Launches Share Purchase Plan; Shares Plummet 8..
MT
02/25OPYL : Business Update & Appendix 4D
PU
02/24Opyl Limited Reports Earnings Results for the Half Year Ended December 31, 20..
CI
02/24OPYL : Implements Unmarketable Parcel Share Sale Facility
PU
01/29OPYL : Appendix 4C – Quarter (Q1) ending 31 December 2020
PU
More news
News in other languages on OPYL LIMITED

- No features available -

More news
Chart OPYL LIMITED
Duration : Period :
Opyl Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Michelle Gallaher Chief Executive Officer
Julian J. Chick Chairman
Marc Angelone Engineering Director
Damon Rasheed Executive Director
Marat Basyrov Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
OPYL LIMITED-22.86%5
VEEVA SYSTEMS INC.10.98%46 354
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-47.51%20 822
OMNICELL, INC.33.79%6 981
PRO MEDICUS LIMITED74.97%4 538
SECTRA AB (PUBL)28.70%4 188